checkAd

Philips Slips After 2022 Guidance Comes in Below Consensus Expectations

(PLX AI) – Philips shares slipped in early trading after the company gave new guidance for 2022 below consensus expectations. Philips sees 3-5% comparable sales growth for 2022 despite an expected decline at the beginning of the year, as well as a …

  • (PLX AI) – Philips shares slipped in early trading after the company gave new guidance for 2022 below consensus expectations.
  • Philips sees 3-5% comparable sales growth for 2022 despite an expected decline at the beginning of the year, as well as a 40-90 basis-points improvement in adj. EBITDA margin
  • The sales growth outlook is 1% below revenue consensus
  • The margin outlook implies a 6% cut to the adjusted EBITDA consensus

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 24,84€, was eine Steigerung von +4,96% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
Übernehmen
Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
WerbungDisclaimer
Wertpapier


0 Kommentare
Autor: PLX AI
 |  120   |  0   |   

Schreibe Deinen Kommentar

Disclaimer

Philips Slips After 2022 Guidance Comes in Below Consensus Expectations (PLX AI) – Philips shares slipped in early trading after the company gave new guidance for 2022 below consensus expectations. Philips sees 3-5% comparable sales growth for 2022 despite an expected decline at the beginning of the year, as well as a …

Nachrichten des Autors

Titel
Willis Towers Watson Increases Share Repurchase Program by $1 Billion, Approves Regular Quarterly ...
Medtronic Q4 Earnings Below Consensus; Sees 2023 Organic Growth 4-5%
Broadcom Buys VMware for $61 Billion in Cash, Shares
Dollar Tree Q1 Earnings Better Than Expected, but Q2 Guidance Slightly Below
Peloton Amends $1.25 Billion Credit Agreements
Autogrill Q1 Underlying EBIT EUR -34 Million
Ulta Beauty Q1 Earnings Beat Consensus; Guidance Raised
Marvell Technology Q1 Earnings Top Expectations; Q2 Guidance Ahead of Consensus
Broadcom Q2 Earnings Beat Expectations; Q3 Guidance Above Consensus
Dollar General Q1 Earnings Beat Expectations; Guidance Raised
Titel
Bavarian Nordic Surges Another 22% as Monkeypox Vaccine Could Be Game Changer, Danske Says
Bavarian Nordic May Benefit from Monkeypox Vaccine Stockpiling, Nordea Says
NVIDIA Shares Drop After Q2 Revenue Outlook Below Consensus Even as Q1 Earnings Beat
Hexagon Purus No Longer Potential Supplier to Commercial Truck OEM
Hexagon Purus Dives 22% After Losing Potential $2 Billion Truck Battery Contract
Siemens Sells Commercial Vehicles Business to Meritor for Enterprise Value EUR 190 Million
Vestas Jumps 5% as Siemens Gamesa Deal Shows Wind Industry Potential, Analysts Say
Nordex Outlook FY Revenue EUR 5,200-5,700 Million
Nordex Cuts FY Outlook for Revenue, EBITDA Margin
TAG Immobilien Q1 FFO at EUR 47.8 Million; FY Guidance Unchanged
Titel
Telefonica Subsidiary Telefonica Tech Buys BE-terna Group for up to EUR 350 Million
Plug Power Q1 Revenue Below Expectations; Keeps FY Targets Unchanged
TeamViewer Q1 Adjusted EBITDA EUR 83.2 Million vs. Estimate EUR 62 Million
Bavarian Nordic Surges Another 22% as Monkeypox Vaccine Could Be Game Changer, Danske Says
Nel Q1 Revenue NOK 213 Million vs. Estimate NOK 248 Million
Tomra Systems Q1 EBITA NOK 237 Million vs. Estimate NOK 248 Million
Vonovia Q1 Net Income EUR -29.1 Million
Bavarian Nordic May Benefit from Monkeypox Vaccine Stockpiling, Nordea Says
Sixt Hit by Cyber Attack, Says Impact Was Minimized
AbbVie Q1 Adj. EPS Tops Estimates; Guidance Cut on Milestone Expense
Titel
Nokia Reinstated with Neutral Rating at Bank of America
Stillfront buys Jawaker for USD 205 Million in Cash and Shares; to Issue New Shares for SEK 1 ...
Dentsply Sirona Fired CEO Casey; Board Member Groetelaars Takes Over Temporarily
Viatris Sells Biosimilars Portfolio to Biocon Biologics for up to $3.335 Bilion
Novo Nordisk Rises as Wegovy Demand Leads to Shortage in U.S.
Rexel Buys Mayer for Enterprise Value $456 Million
Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap
Nordex Rises as Bank of America Sees Strong Orders in Q3
Plug Power Q4 Revenue Beats Expectations; Sees Fuel Margins Breakeven by 2023
Amazon Jumps 7% After Earnings; Takes $11.8 Billion Gain from Rivian